Cargando…
CD70: A Potential Target in Breast Cancer?
CD70 is a co-stimulatory molecule involved in the immune response and also in cancer development and progression. Recent studies show that high CD70 expression in cancer cells may inhibit the anti-tumor response. Furthermore, CD70 expression has been reported as a predictive marker of resistance to...
Autores principales: | Petrau, Camille, Cornic, Marie, Bertrand, Philippe, Maingonnat, Catherine, Marchand, Vinciane, Picquenot, Jean-Michel, Jardin, Fabrice, Clatot, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216800/ https://www.ncbi.nlm.nih.gov/pubmed/25368676 http://dx.doi.org/10.7150/jca.10360 |
Ejemplares similares
-
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?
por: Dubois, Sydney, et al.
Publicado: (2015) -
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor
por: Clatot, Florian, et al.
Publicado: (2016) -
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
por: Bohers, Elodie, et al.
Publicado: (2018) -
Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma
por: Fontanilles, Maxime, et al.
Publicado: (2017) -
Breast papillary lesions: an analysis of 70 cases
por: Boin, Dahiana Pulgar, et al.
Publicado: (2014)